+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Use of a prefilled insulin syringe (Novolin Prefilled) by patients with diabetes

Use of a prefilled insulin syringe (Novolin Prefilled) by patients with diabetes

Clinical Therapeutics 15(2): 423-431

A study was conducted to assess patients' acceptance of a new insulin injection system, Novolin Prefilled, and to record their opinions about its use during a 4-week study period. Sixty-four patients, aged 20 to 69 years, with type I (n = 19) or type II (n = 45) diabetes mellitus entered and completed the study; 22 were new insulin users and 42 had been treated previously for 6 months to 43 years.

(PDF emailed within 1 workday: $29.90)

Accession: 009703267

Download citation: RISBibTeXText

PMID: 8519048

Related references

Patients' perceptions of subcutaneous delivery of darbepoetin alfa by autoinjector prefilled pen versus prefilled syringe: a randomized, crossover study. Clinical Therapeutics 34(9): 1948-1953, 2013

Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers, and healthcare professionals. Current Medical Research and Opinion 29(5): 475-481, 2013

Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes. Journal of Diabetes Science and Technology 4(3): 547-557, 2010

Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe. Journal of Medical Economics 14(1): 75-86, 2011

Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore. Clinical Therapeutics 36(7): 1043-1053, 2015

Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning. Current Medical Research and Opinion 28(1): 3-13, 2012

An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen. Expert Opinion on Drug Delivery 8(10): 1271-1276, 2012

Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses. Expert Opinion on PharmacoTherapy 13(13): 1837-1846, 2013

A multicenter, randomized, open-label, comparative,two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clinical Therapeutics 25(11): 2836-2848, November, 2003

A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technology & Therapeutics 13(12): 1207-1211, 2012

A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technology & Therapeutics 11(10): 657-661, 2010

Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe. Expert Opinion on Drug Delivery 9(10): 1181-1196, 2013

Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals. Expert Opinion on Drug Delivery 11(9): 1381-1389, 2014

Perceptions of Usability and Design for Prefilled Insulin Delivery Devices for Patients With Type 2 Diabetes. Diabetes Spectrum 26(1): 16-28, 2013

Competency of prefilled insulin pen usage among diabetes patients in Saudi Arabia: a cross-sectional study. Current Diabetes Reviews, 2018